Daniel. He has a point.... PIQ has been bringing PromarkerD to commercialisation for well over 5 years. PIQ needs sales, and they need to be consuming major market share YESTERDAY, otherwise the big pharmas will simply dominate at the flick of a finger.
PIQ has unfortunately not provided their commercialisation plan. (Do they even have one?). Left field Drip and drab announcements such as this one do not provide confidence to investors. They come out of nowhere and investors are left to try and piece together where these announcements fit within the overall commercialisation plan. A commercialisation plan is required. A pity really because the technology is so promising, but without a clear plan with objectives and goals, it won't go anywhere. A commercial board is required for this stage, not a scientific one. my 2 cents anyway.
PIQ Price at posting:
48.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)